ARWR
Arrowhead Pharmaceuticals, Inc.
Revenue to net incomeFY2019
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $451M | +26.7% |
| Operating income | −$707M | — |
| Net income | −$724M | — |
| EPS | −$5.11 | — |
| Free cash flow | −$284M | — |
Arrowhead Pharmaceuticals, Inc.
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $451M | +26.7% |
| Operating income | −$707M | — |
| Net income | −$724M | — |
| EPS | −$5.11 | — |
| Free cash flow | −$284M | — |